Clinical Trials Saved My Life
By Mara Klecker When Barbara Hunter found out her melanoma had returned as Stage IV and was in her liver,…
01/02/2024
Clinical Trials Saved My Life
By Mara Klecker When Barbara Hunter found out her melanoma had returned as Stage IV and was in her liver,…
|
12/19/2023
Navigating Melanoma During the Holidays
The holiday season is often portrayed as a time of joy, love, and celebration. However, for melanoma cancer patients, it…
|
12/18/2023
The Clinical Trial Experience: A Patient’s Perspective
In 2010, Mary Elizabeth Williams was diagnosed with metastatic melanoma. The following year, she was offered the opportunity to participate…
|
12/05/2023
Celebrate Survivorship – Give Towards Melanoma Research
Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
|
11/14/2023
Melanoma Cancer and Financial Toxicity
While being diagnosed with cancer alone can put a person under tremendous amounts of mental and emotional stress, the additional…
|
10/31/2023
National Family Caregiver Month
National Caregiver Month is observed every November to honor and appreciate the selfless individuals who dedicate their lives to caring…
|
10/23/2023
Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial Published: Oct 21, 2023 Data published in New…
|
|
10/15/2023
Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
|
|
10/13/2023
That Good Night: Life and Medicine in the Eleventh Hour
A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
|
09/17/2023
Notes from the Lab: Novel targets for immune checkpoint inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
|
Entradas recientes
Apr. 16, 2024
Navigating the Journey Together – Conversations with Melanoma Caregivers
Apr. 12, 2024
May is Brain Tumor Awareness Month
Apr. 11, 2024
President’s Letter | April 2024
Apr. 11, 2024
Celebrating a Milestone: 20 Years of the Dallas Steps Against Melanoma Walk
Apr. 11, 2024